News | Treatment Planning | January 30, 2018

RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital

Treatment planning system will be employed at U.K. hospitals for 3-D-CRT, IMRT, VMAT and other adaptive planning applications

RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital

January 30, 2018 — Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for two sites in London: Charing Cross Hospital and Hammersmith Hospital. RayStation was selected following a thorough evaluation of all potential treatment planning systems on the market.

The Imperial College Healthcare NHS Trust operates five hospitals in London, plus a range of community health services. Its radiation therapy services are provided at Charing Cross Hospital and Hammersmith Hospital. RayStation will replace two different treatment planning systems currently in use at the hospitals.

The two hospitals will use RayStation for all radiation therapy treatment planning activities, as well as all pre-treatment virtual simulation. RayStation will replace the hospitals’ current standalone system for virtual simulation. The purchase comprises a broad range of functionality, including three-dimensional conformal radiation therapy (3-D-CRT), intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), multi-criteria optimization (MCO), automated breast planning and adaptive planning.

RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines features such as MCO tools with full support for 4-D adaptive radiation therapy. It also includes functionality such as RaySearch’s algorithms for IMRT and VMAT optimization, and highly accurate dose engines for photon, electron, proton and carbon ion therapy.

For more information: www.raysearchlabs.com

 

Related Content

Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
Videos | Prostate Cancer | September 30, 2019
Bill Hartsell, M.D., medical director of the Northwestern Medicine Proton Center in Warrenville, Ill., discusses the